nivolumab
bms
['nivolumab', 'nivo', 'headandneck', 'scchn']
skcc at #asco22: new research into #headandneckcancer, including a phase i #clinicaltrial of a novel photoimmunotherapy treatment, neoadjuvant nivolumab with &amp; without an ido inhibitor, and a new prognostic model for first-line treatment of recurrent or metastatic #scchn. 
Our mission is to improve the lives of cancer patients and their families through compassion, innovation, and breakthrough discoveries. #UntilEveryCancerIsCured